FES anticorps (AA 13-822) (Cy3)
Aperçu rapide pour FES anticorps (AA 13-822) (Cy3) (ABIN7990192)
Antigène
Voir toutes FES AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 13-822
-
Fonction
- Anti-FES Antibody Cy3 Conjugated
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogène
- E.coli-derived human FES recombinant protein (Position: H13-R822).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Flow Cytometry, 1-3 μg/1x106 cells
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Date de péremption
- 12 months
-
-
- FES (Feline Sarcoma Oncogene (FES))
-
Autre désignation
- FES
-
Sujet
-
Background: FES(feline sarcoma oncogene) is an enzyme that in humans is encoded by the FES gene. This gene encodes the human cellular counterpart of a feline sarcoma retrovirus protein with transforming capabilities. Non-onc intervening sequences were present in the human counterpart. The gene product has tyrosine-specific protein kinase activity and that activity is required for maintenance of cellular transformation. Its chromosomal location has linked it to a specific translocation event identified in patients with acute promyelocytic leukemia, but it is also involved in normal hematopoiesis. A truncated transcript has been identified that is generated utilizing a start site in one of the far downstream exons but a protein product associated with this transcript has not been identified.
Gene Full Name: FES proto-oncogene, tyrosine kinase
-
ID gène
- 2242
-
UniProt
- P07332
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Signaling Events mediated by VEGFR1 and VEGFR2
Antigène
-